Sutton Wealth Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,315
Closed -$33.3K 1708
2022
Q3
$33.3K Sell
1,315
-30
-2% -$1.05K 0.01% 490
2022
Q2
$44.7K Buy
1,345
+1,329
+8,306% +$56.4K 0.02% 411
2022
Q1
$1.15K Buy
16
+15
+1,500% +$1.08K ﹤0.01% 1306
2021
Q4
$92 Sell
1
-1
-50% -$120 ﹤0.01% 1663
2021
Q3
$254 Buy
2
+1
+100% +$146 ﹤0.01% 1291
2021
Q2
$166 Sell
1
-10
-91% -$1.62K ﹤0.01% 1276
2021
Q1
$2K Buy
11
+8
+267% +$1.86K ﹤0.01% 1138
2020
Q4
$600 Sell
3
-4
-57% -$813 ﹤0.01% 1206
2020
Q3
$1.53K Buy
7
+4
+133% +$847 ﹤0.01% 1098
2020
Q2
$573 Buy
+3
New +$526 ﹤0.01% 1156

Other funds holding TDOC

Sutton Wealth Advisors's TDOC Position: Q4 2022 in Review

Sutton Wealth Advisors sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 1,315 shares — an estimated $33.3K sold.

Sutton Wealth Advisors first reported a position in TDOC in Q2 2020 and held it in 10 quarters. The position peaked at $44.7K in Q2 2022. 443 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

  • Sutton Wealth Advisors reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
  • Sutton Wealth Advisors sold 1,315 Teladoc Health shares in Q4 2022, an estimated $33.3K.
  • Sutton Wealth Advisors first reported a position in Teladoc Health in Q2 2020 and held it in 10 quarters.
  • Sutton Wealth Advisors's Teladoc Health position peaked at $44.7K in Q2 2022.
  • 443 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on Sutton Wealth Advisors's 13F filing for Q4 2022, filed 7 Nov 2023.